170 related articles for article (PubMed ID: 17047132)
1. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.
Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
Gut; 2006 Nov; 55(11):1682-3. PubMed ID: 17047132
[No Abstract] [Full Text] [Related]
2. [A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin for chronic hepatitis C].
Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
Nihon Shokakibyo Gakkai Zasshi; 2006 Sep; 103(9):1061-6. PubMed ID: 16953104
[TBL] [Abstract][Full Text] [Related]
3. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
Sprenger R; Sagmeister M; Offner F
Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
[No Abstract] [Full Text] [Related]
4. Development of pouchitis with combination therapy with peg-interferon alpha-2b and ribavirin for chronic hepatitis C in a patient with ulcerative colitis who underwent pouch surgery.
Morimoto K; Yamagami H; Hosomi S; Ohira M; Suekane T; Kamata N; Sogawa M; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Tamori A; Oshitani N; Arakawa T
Am J Gastroenterol; 2009 Jun; 104(6):1609-10. PubMed ID: 19491886
[No Abstract] [Full Text] [Related]
5. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
6. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
Shafa S; Borum ML; Igiehon E
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
[No Abstract] [Full Text] [Related]
7. Diagnosis of inflammatory bowel disease in chronic hepatitis C patients treated with pegylated interferon and ribavirin: coincidence or consequence?
Salgueiro P; Lago P; Pedroto I
J Crohns Colitis; 2013 Jun; 7(5):e194. PubMed ID: 23219260
[No Abstract] [Full Text] [Related]
8. Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
Meyer-Wyss B; Rich P; Egger H; Helbling B; Müllhaupt B; Rammert C; Gonvers JJ; Oneta C; Criblez D; Rossi L; Borovicka J; Meyenberger C; Arn M; Renner EL;
J Viral Hepat; 2006 Jul; 13(7):457-65. PubMed ID: 16792539
[TBL] [Abstract][Full Text] [Related]
9. Pernicious anemia during peginterferon-alpha2b plus ribavirin therapy for chronic hepatitis C.
Musialik J; Petelenz M; Błoñska-Fajfrowska B; Hartleb M
Eur J Gastroenterol Hepatol; 2009 May; 21(5):593-4. PubMed ID: 19194303
[No Abstract] [Full Text] [Related]
10. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
[No Abstract] [Full Text] [Related]
11. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege.
Ito T; Suzuki T; Funakoshi A; Tokura Y
Eur J Dermatol; 2014; 24(5):631-3. PubMed ID: 25115439
[No Abstract] [Full Text] [Related]
12. Hematologic side effects of PEG interferon and ribavirin. Management with growth factors.
Keeffe EB; Kowdley KV
J Clin Gastroenterol; 2005 Jan; 39(1 Suppl):S1-2. PubMed ID: 15597022
[No Abstract] [Full Text] [Related]
13. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection.
Shen Y; Pielop J; Hsu S
Arch Dermatol; 2005 Jan; 141(1):102-3. PubMed ID: 15655158
[No Abstract] [Full Text] [Related]
14. Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C.
Tursi A
Inflamm Bowel Dis; 2007 Sep; 13(9):1189-90. PubMed ID: 17427238
[No Abstract] [Full Text] [Related]
15. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
16. Ulcerative colitis triggered by pegylated interferon alone therapy for chronic hepatitis C.
Altınbas A; Koybasıoglu F; Aktas E; Yılmaz B; Coban S
Inflamm Bowel Dis; 2011 Apr; 17(4):1050. PubMed ID: 20623698
[No Abstract] [Full Text] [Related]
17. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
Enjoji M; Dainichi T; Gondo H; Urabe K
Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
[TBL] [Abstract][Full Text] [Related]
18. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
[No Abstract] [Full Text] [Related]
19. Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C.
Elefsiniotis IS; Pantazis KD; Fotos NV; Moulakakis A; Mavrogiannis C
J Gastroenterol Hepatol; 2006 Mar; 21(3):622-3. PubMed ID: 16638114
[TBL] [Abstract][Full Text] [Related]
20. Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
Miura Y; Kami M; Yotsuya R; Toda N; Komatsu T
Am J Hematol; 2008 Sep; 83(9):758-9. PubMed ID: 18615552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
